Alexion Pharmaceuticals
Tracie Treleaven is a Senior Scientist In Vivo Coordinator at Alexion Pharmaceuticals, Inc., a position held since September 2023. Prior to this role, Tracie served as a Senior Scientist In Vivo Coordinator at Pfizer from September 2022 to September 2023. Tracie's career in the pharmaceutical industry began at Genzyme, where completion of responsibilities occurred as a Principal Research Associate and Scientist from 2003 to September 2023. Tracie holds a Bachelor of Science degree from the University of Massachusetts Amherst, obtained between 1999 and 2003, and an Associate's degree in Horse Husbandry/Equine Science and Management from the Stockbridge School of Agriculture, attained from 1999 to 2001.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.